Attachment 00_Combined Synopsis_Solicitation.pdf
PDF 246 KB Posted
- Attached to
- BioFire Respiratory 2. 1 (RP2. 1) Panel with SARS-CoV-2 (COVID-19) Federal contract opportunity
- Solicitation number
- FA8052-20-R-0026
About this file
This combined synopsis/solicitation requests proposals for the BioFire Respiratory 2.1 Panel with SARS-CoV-2, which detects 22 respiratory pathogens including SARS-CoV-2. Offerors are to provide the BioFire Respiratory 2.1 Panel compatible with BioFire analyzers under a firm-fixed-price contract with a base period of performance from September 2020 to September 2021. Proposals are due by 2:00PM on September 18, 2020 and are to be submitted to the contracting officer and contract specialist at the provided email addresses. Proposals will be evaluated using the lowest price technically acceptable process, and award may be made without discussions. The requirement is being issued by the 773d Enterprise Sourcing Squadron on behalf of the Department of the Air Force Materiel Command Installation and Mission Support Center Installation Contracting Agency. The associated NAICS code is 325413 for in-vitro diagnostic substance manufacturing.
View the file
Other files for this federal contract opportunity
| File | Type | Posted |
|---|---|---|
| Attachment 02_Physical Addresses_Delivery Schedule.xlsx | XLSX spreadsheet | |
| Attachment 01_Product Description.pdf | ||
| Attachment 03_Provisions_Clauses.pdf |
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
DEPARTMENT OF THE AIR FORCE
AIR FORCE INSTALLATION CONTRACTING CENTER
Fly, Fight and Win - Through agile, innovative and mission-focused business solutions
MEMORANDUM FOR BIOFIRE DEFENSE, LLC
79 W 4500 S STE 14
SALT LAKE CITY, UT, 84107-2663
FROM: 773D ENTERPRISE SOURCING SQUADRON
3515 S. GENERAL MCMULLEN, STE. 200
SAN ANTONIO, TX, 78226
SUBJECT: Combined Synopsis/Solicitation, Number FA8052-20-R-0026, for BioFire Respiratory 2.1 (RP2.1) Panel with SARS-CoV-2 (COVID-19)
This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice and attached Product Description, and Physical Address and Delivery Schedule. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. Combined synopsis/solicitation number FA8052-20-R-0026 is issued as a request for proposal (RFP), entitled BioFire Respiratory 2.1 (RP2.1) Panel with SARS-CoV-2 (COVID-19).
1. Introduction. The 773d Enterprise Sourcing Squadron (773 ESS/PK) intends to award a firm-fixed-price (FFP), commercial item contract. Potential Offerors are to review and address this combined synopsis/solicitation and all attachments which include the Product Description, and Physical Address and Delivery Schedule dated 14 September 2020 and all applicable provisions and clauses. FAILURE TO PROVIDE ANY REQUIRED INFORMATION
MAY RESULT IN AN OFFER BEING DETERMINED NON-RESPONSIVE.
2. Requirement. This requirement is to provide BioFire® Respiratory 2.1 (RP2.1) Panel with SARS-CoV-2. The BioFire® Respiratory 2.1 (RP2.1) Panel with SARS-CoV-2 should not only detect SARS-CoV-2, but also detect 21 additional respiratory pathogens to help clinicians quickly rule in and rule out other common causes of respiratory illness. Furthermore, the BioFire® Respiratory 2.1 (RP2.1) Panel with SARS-CoV-2 shall be compatible for use on both the BioFire 2.0, BioFire Torch, and/or other BioFire analyzers. The associated NAICS code is 325413, In-Vitro Diagnostic Substance Manufacturing, with a size standard of 1,250 employees.
3. Period of Performance (POP). Due to current production limitations the contract will have a 12-month period of performance with distribution in accordance with the attached Physical Address and Delivery Schedule. The estimated award date is 28 September 2020.
Estimated Schedule POP Start POP End Base Period 28 September 2020 27 September 2021
4. CLIN Structure. The contract will consist of CLIN 0001, BioFire® Respiratory 2.1 (RP2.1) Panel with SARS-CoV-2 with a unit of issue based on 30-pack units, and CLIN 0002 for Shipping/Delivery.
5. Basis of Award. All proposals will be evaluated in accordance with FAR 15.101-2, Lowest Price Technically Acceptable Source Selection Process. Award may be made with or without discussions with the Offeror(s). Award of this contract will be based on Offeror’s eligibility status as determined by SAM and FAPIIS, technical acceptance and overall fair and reasonable pricing. Each CLIN will be individually evaluated for price fair and reasonableness.
6. Proposal Requirement. The Offeror’s proposal shall be based upon the Product Description, and Physical Address and Delivery Schedule dated 14 September 2020 and all applicable provisions and clauses. Additionally, an Offeror’s proposal shall include the following:
a. Proposal Cover Sheet. The Proposal Cover Sheet shall include a point of contact that is authorized to commit the company; company address and phone number; the audit office with a point of contact/phone number; the administration office with a point of contact/phone number; and any other information that will be important in evaluating the proposal.
b. Technical Proposal. The technical proposal shall represent a comprehensive technical and management approach to accomplish the effort identified in the Product Description, and Physical Address and Delivery Schedule. The technical proposal shall describe the Offeror’s understanding of the effort to be undertaken and a description of how the Offeror’s firm plans to meet and satisfy these requirements.
c. Price/Cost Proposal. The price/cost proposal will deliniate CLIN 0001, BioFire® Respiratory 2.1 (RP2.1) Panel with SARS-CoV-2 with a unit of issue based on 30-pack units, and CLIN 0002 for Shipping/Delivery.
d. Exceptions/Assumptions. The Offeror shall include a statement of any exceptions taken, or assumptions made, to the items or delivery schedule delineated in the Product Description, and Physical Address and Delivery Schedule, or with the Government’s stated period of performance. All assumptions and exceptions shall be listed on a separate page in the proposal and clearly identified.
7. Contact Information. Submit all questions in writing to the Contracting Officer, Larry S.
Conger at larry.conger.1@us.af.mil and courtesy copy the Contract Specialist, Nathaniel W.
Trulove at nathaniel.trulove.3@us.af.mil.
8. Proposal Due Time/Date. Submit electronic copies of the Proposal Cover Sheet, Technical Volume, Price/Cost Volume and Exceptions/Assumptions to the Contracting Officer, Larry S.
Conger at larry.conger.1@us.af.mil and courtesy copy the Contract Specialist, Nathaniel W.
Trulove at nathaniel.trulove.3@us.af.mil no later than 2:00 PM (Central Standard Time) on 18 September 2020.
mailto:larry.conger.1@us.af.mil mailto:nathaniel.trulove.3@us.af.mil mailto:larry.conger.1@us.af.mil mailto:nathaniel.trulove.3@us.af.mil
9. This combined synopsis/solicitation notice should not be construed as authority to proceed or the acquisition of items is assured, as successful negotiations are a prerequisite to the issuance of a contract award. Performance on this effort shall not proceed until the Offeror receives direction from the Contracting Officer or issuance of an executed contract award.
10. The Contracting Officer is the only official with the authority to bind the Government contractually. Technical representatives of the Government are not authorized to make binding contractual decisions regarding price, schedule, quality, or quantity.
LARRY S. CONGER
Contracting Officer
3 Attachments:
1. Product Description
2. Physical Addresses_Delivery Schedule
3. Provisions_Clauses
| Base Period: | |
| 2020-09-15T07:50:08-0500 | |
| CONGER.LARRY.S.1153600038 |
File details come from the government source that posted it. Updated .